.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Terazosin hydrochloride - Generic Drug Details

« Back to Dashboard
Terazosin hydrochloride is the generic ingredient in two branded drugs marketed by Ivax Sub Teva Pharms, Sandoz, Jubilant Cadista, Ranbaxy Labs Ltd, Mylan, Teva, Abbott, Mylan Technologies, and Apotex, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-four drug master file entries for terazosin hydrochloride. Twenty-five suppliers are listed for this compound.

Summary for Generic Name: terazosin hydrochloride

Tradenames:2
Patents:0
Applicants:9
NDAs:14
Drug Master File Entries: see list24
Suppliers / Packaging: see list25
Therapeutic Class:Cardiovascular Agents
Genitourinary Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: terazosin hydrochloride

Clinical Trials for: terazosin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz
TERAZOSIN HYDROCHLORIDE
terazosin hydrochloride
TABLET;ORAL074315-002Dec 31, 1998DISCNNo
Sandoz
TERAZOSIN HYDROCHLORIDE
terazosin hydrochloride
TABLET;ORAL074657-001Apr 28, 2000DISCNNo
Sandoz
TERAZOSIN HYDROCHLORIDE
terazosin hydrochloride
CAPSULE;ORAL075667-001Jul 28, 2000DISCNNo
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: terazosin hydrochloride

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbott
HYTRIN
terazosin hydrochloride
CAPSULE;ORAL020347-003Dec 14, 19944,251,532<disabled>
Abbott
HYTRIN
terazosin hydrochloride
CAPSULE;ORAL020347-004Dec 14, 19945,294,615<disabled>
Abbott
HYTRIN
terazosin hydrochloride
TABLET;ORAL019057-003Aug 7, 19874,026,894<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc